Raymond James Financial
PROF

Raymond James Financial’s Profound Medical PROF Stock Holding History

Raymond James Financial’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$973K Buy
150,157
+14,872
+11% +$103K ﹤0.01% 3869
2025
Q4 		$1.06M Sell
135,285
-16,226
-11% -$104K ﹤0.01% 3732
2025
Q3 		$741K Sell
151,511
-790,368
-84% -$4.03M ﹤0.01% 3868
2025
Q2 		$5.56M Buy
941,879
+49,000
+5% +$259K ﹤0.01% 2307
2025
Q1 		$5.2M Buy
892,879
+17,170
+2% +$119K ﹤0.01% 2303
2024
Q4 		$6.58M Buy
+875,709
New +$6.72M ﹤0.01% 2145

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
ZCP
Z3 Capital Partners Richmond, Virginia $395M AUM
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Raymond James Financial's PROF Position: Q1 2026 in Review

Raymond James Financial increased its Profound Medical (PROF) stake by 11% in Q1 2026, buying an estimated $103K and bringing the position to 150,157 shares worth $973K. The position accounts for ﹤0.01% of the portfolio, ranked #3869.

Raymond James Financial first reported a position in PROF in Q4 2024 and has held it in 6 quarters since. The position peaked at $6.58M in Q4 2024. 57 funds tracked by Wall St. Rank hold PROF as of Q1 2026.

  • Raymond James Financial held 150,157 shares of Profound Medical worth $973K as of Q1 2026.
  • Raymond James Financial bought 14,872 Profound Medical shares in Q1 2026, an estimated $103K.
  • Profound Medical made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #3869 holding.
  • Raymond James Financial first reported a position in Profound Medical in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's Profound Medical position peaked at $6.58M in Q4 2024.
  • 57 funds tracked by Wall St. Rank held Profound Medical as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.